세계의 수면무호흡증용 구강내 장치 시장 : 제품별, 성별, 구매 유형별, 연령대별, 유통 채널별, 최종사용자별, 지역별 - 예측(-2029년)

The global sleep apnea oral appliances market is valued at an estimated 746.6 million in 2029 and is projected to reach USD 471.2 million by 2024, at a CAGR of 9.6% during the forecast period. The increasing number of undiagnosed sleep apnea patient has led to a growing need of sleep apnea oral appliances. The demand for sleep apnea oral appliances is therefore expected to increase as prevalence of obstructive sleep apnea is growing.

"The physician-prescribed/customized oral appliances segment is projected to witness the highest growth rate in the sleep apnea oral appliances market, by purchase type, during the forecast period."

Based on purchase type, the sleep apnea oral appliances market is segmented into physician-prescribed/customized oral appliances and online over-the-counter (OTC) oral appliances. The failure of the CPAP therapy has boosted the demand for physician-prescribed oral appliances. A custom fit oral appliance is needed as it provide a comfortable fit for the long usage.

"The male patients segment is projected to witness the highest growth rate in the sleep apnea oral appliances market, in 2023, by gender"

Based on gender, the sleep apnea oral appliances market is segmented into male patients and female patients. The male patients experience higher rate of sleep apnea than female patients due to their physical structures in the upper airway length and other biological factors.

"The Asia Pacific region is projected to witness highest growth rate in the sleep apnea oral appliances market during the forecast period"

The global sleep apnea oral appliances market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the sleep apnea oral appliances marketis expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such government initiatives to raise awareness about infection control.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 50%, and Tier 3 - 10%
• By Designation: C-level - 48%, Director-level - 37%, and Others - 15%
• By Region: North America - 46%, Europe - 26%, Asia Pacific - 15%, Latin America - 6%, Middle East & Africa - 4%, and the GCC Countries - 3%

Lists of Companies Profiled in the Report:

SomnoMed (Australia), ResMed (US), ProSomnus Sleep Technologies (US), DynaFlex (US), Vivos Therapeutics, Inc. (US), Openairway (Canada), Panthera Dental (Canada), Airway management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC. (US), Braebon Medical Corporation (Canada), MPowrx Health and Wellness Products (US), The Snore Reliever Company, LLC (US), Tomed GmbH (Germany), THE AURUM GROUPS (Canada), ErkodentErich Kopp GmbH (Germany), OSCIMED SA (Switzerland), SICAT GmbH & Co. KG (Germany), Glidewell (US), ApnoMed (US), Zquiet (US), Dream Systems Dental Sleep Lab (US), ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC (UAE), OrthoApnea (Spain), and DOC BRANDS, INC. (US).

Study Coverage:

In this report, the sleep apnea oral appliances market has been categorized based on product (mandibular advancement devices, tongue-retaining devices, and daytime-nighttime appliances ), purchase type (physician-prescribed/customized oral appliances and online over-the-counter (OTC) oral appliances), gender (male patients and female patients), age group (40 years, between 40-60 years, and above 60 years), distribution channel (online pharmacies, retail pharmacies, and hospital pharmacies & dental clinics), end user (home care settings/individuals, hospitals, and dental clinics), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the GCC Countries).

Information regarding the main drivers, restraints, opportunities, and challenges influencing the sleep apnea oral appliances market's expansion is includes detail in this study. An intensive study of the key players in the sleep apnea oral appliances market has been done to provide insights into their business profile, service offered, note worthy strategies, acquisitions and expansions, and other deals made pertaining to the market. This study examines the fragmented landscape of emerging sleep apnea oral appliances startups.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea oral appliances marketand the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints.

The report provides insights on the following pointers:

• Analysis of key drivers: (Large pool of undiagnosed sleep apnea patients globally, growing awareness about effects of untreated sleep apnea among patients, growing usage of oral appliances among patients with mild-to-moderate sleep apnea, and rising number of companies in sleep apnea devices and oral appliances market ), restraints (high prices of customized oral appliances, alternative therapies and medications for sleep apnea, risks associated with oral appliance therapy for obstructive sleep apnea, opportunities (growing demand for home sleep apnea tests as cost-saving measure, increasing focus on telemedicine, mhealt, and AI, poor compliance associated with CPAP, increased interest of sleep apnea device manufacturers in emerging markets), and challenges (complex referral pathways and long waiting periods) influencing the growth of the in sterilization services market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the sleep apnea oral appliances market across varied regions.
• Market Diversification: Exhaustive information about untapped geographies, and investments in the sleep apnea oral appliances market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like include SomnoMed (Australia), ResMed (US), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US) are among others, in the sleep apnea oral appliances market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Approach 3: Patient-based approach
    • 2.2.1.4 Growth forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ASSUMPTIONS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY
• 4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY METHOD AND COUNTRY (2023)
• 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Large pool of undiagnosed sleep apnea patients globally
    • 5.2.1.2 Growing awareness about effects of untreated sleep apnea among patients
    • 5.2.1.3 Growing usage of oral appliances among patients with mild-to-moderate sleep apnea
    • 5.2.1.4 Rising number of companies in sleep apnea devices and oral appliances market
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High prices of customized oral appliances
    • 5.2.2.2 Alternative therapies and medications for sleep apnea
    • 5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing demand for home sleep apnea tests as cost-saving measure
    • 5.2.3.2 Increasing focus on telemedicine, mHealth, and AI
    • 5.2.3.3 Poor compliance associated with CPAP
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Complex referral pathways and long waiting periods
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2021-2023
  • 5.3.2 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2021-2023
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
  • 5.6.1 SLEEP APNEA ORAL APPLIANCES MARKET: ROLE IN ECOSYSTEM
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.1.1 North America
      • 5.8.1.1.1 US
        • 5.8.1.1.1.1 Reimbursement scenario in US
      • 5.8.1.1.2 Canada
    • 5.8.1.2 Europe
    • 5.8.1.3 Asia Pacific
      • 5.8.1.3.1 Japan
      • 5.8.1.3.2 China
      • 5.8.1.3.3 India
      • 5.8.1.3.4 Australia
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Latin America
    • 5.8.2.5 Middle East & Africa
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Mandibular advancement devices
  • 5.9.2 ADJACENT TECHNOLOGIES
    • 5.9.2.1 Daytime-nighttime appliances
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019-2023 (USD MILLION)
  • 5.10.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019-2023 (USD MILLION)
• 5.11 PATENT ANALYSIS
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 IMPACT OF GENERATIVE AI ON SLEEP APNEA ORAL APPLIANCES MARKET
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 END-USER PERCEPTION ANALYSIS
• 5.18 PURCHASING DECISION-MAKING PROCESS
  • 5.18.1 INTRODUCTION
    • 5.18.1.1 Need recognition
    • 5.18.1.2 Gathering information
    • 5.18.1.3 Evaluating alternatives

6 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 MANDIBULAR ADVANCEMENT DEVICES
  • 6.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES
    • 6.2.1.1 Low cost of readymade MADs to drive demand
  • 6.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES
    • 6.2.2.1 High efficacy of custom-made MADs to support market demand
• 6.3 TONGUE-RETAINING DEVICES
  • 6.3.1 LOWER SUCCESS RATE OF TRDS TO CHALLENGE MARKET GROWTH
• 6.4 DAYTIME-NIGHTTIME APPLIANCES
  • 6.4.1 HIGHER COMFORT OF DNAS TO DRIVE ADOPTION

7 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER

• 7.1 INTRODUCTION
• 7.2 MALE PATIENTS
  • 7.2.1 HIGHER PREVALENCE OF OSA IN MALES TO BOOST MARKET GROWTH
• 7.3 FEMALE PATIENTS
  • 7.3.1 OSA UNDERDIAGNOSIS IN FEMALES TO RESTRICT MARKET GROWTH

8 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE

• 8.1 INTRODUCTION
• 8.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES
  • 8.2.1 FAILURE OF CPAP THERAPY TO DRIVE DEMAND FOR PHYSICIAN-PRESCRIBED ORAL APPLIANCES
• 8.3 ONLINE OTC ORAL APPLIANCES
  • 8.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH

9 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP

• 9.1 INTRODUCTION
• 9.2 BELOW 40 YEARS
  • 9.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO RESTRICT MARKET GROWTH
• 9.3 BETWEEN 40-60 YEARS
  • 9.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH
• 9.4 ABOVE 60 YEARS
  • 9.4.1 INCREASING BREATHING DISTURBANCES AND SLEEP APNEA TO SUPPORT MARKET GROWTH

10 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL

• 10.1 INTRODUCTION
• 10.2 ONLINE PHARMACIES
  • 10.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
• 10.3 RETAIL PHARMACIES
  • 10.3.1 EASY ACCESS TO PRODUCTS WITH RETAIL PHARMACIES TO BOOST MARKET
• 10.4 HOSPITAL PHARMACIES & DENTAL CLINICS
  • 10.4.1 HIGH PATIENT CONVENIENCE IN HOSPITAL PHARMACIES TO DRIVE DEMAND

11 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 HOME CARE SETTINGS/INDIVIDUALS
  • 11.2.1 RISING PATIENT PREFERENCE FOR ADVANCED HOME SLEEP CARE DEVICES TO DRIVE MARKET
• 11.3 HOSPITALS
  • 11.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE DEMAND FOR ORAL APPLIANCES IN HOSPITALS
• 11.4 DENTAL CLINICS
  • 11.4.1 RISING NUMBER OF DENTAL CLINICS TO BOOST MARKET GROWTH

12 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 Rising availability of grants and funds and increasing trend of home sleep testing to drive market
  • 12.2.3 CANADA
    • 12.2.3.1 Increasing number of research grants and health programs to propel market
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 GERMANY
    • 12.3.2.1 High prevalence of obstructive sleep apnea primarily due to smoking to fuel market
  • 12.3.3 UK
    • 12.3.3.1 Rising awareness among patients and increasing number of sleep service groups to support market
  • 12.3.4 FRANCE
    • 12.3.4.1 Rising geriatric population to increase incidence of sleep apnea
  • 12.3.5 ITALY
    • 12.3.5.1 Growing prevalence of sleep apnea and increasing awareness among patients regarding ill effects of disease to aid market
  • 12.3.6 SPAIN
    • 12.3.6.1 Increasing initiatives for social awareness regarding illness and treatment by regional organizations to drive market
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 Growing adult obesity rates and expanding geriatric population to propel market
  • 12.4.3 JAPAN
    • 12.4.3.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to aid market
  • 12.4.4 AUSTRALIA
    • 12.4.4.1 High prevalence of sleep apnea and increased number of awareness programs to drive market
  • 12.4.5 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 POOR HEALTHCARE INFRASTRUCTURE AND LACK OF PUBLIC HEALTH INITIATIVES TO LIMIT MARKET GROWTH
  • 12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 12.7 GCC COUNTRIES
  • 12.7.1 HIGH OBESITY RATE AMONG WOMEN TO PROPEL MARKET GROWTH
  • 12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET
• 13.3 REVENUE ANALYSIS, 2019-2023
• 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.4.1 RANKING OF KEY MARKET PLAYERS
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Product footprint
    • 13.5.5.3 Purchase type footprint
    • 13.5.5.4 Region footprint
• 13.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
• 13.7 COMPANY VALUATION & FINANCIAL METRICS
• 13.8 BRAND/PRODUCT COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES & APPROVALS
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS
  • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 SOMNOMED
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 MnM view
      • 14.1.1.3.1 Right to win
      • 14.1.1.3.2 Strategic choices
      • 14.1.1.3.3 Weaknesses & competitive threats
  • 14.1.2 RESMED
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
      • 14.1.2.2.1 Deals
      • 14.1.2.2.2 Expansions
    • 14.1.2.3 MnM view
      • 14.1.2.3.1 Right to win
      • 14.1.2.3.2 Strategic choices
      • 14.1.2.3.3 Weaknesses & competitive threats
  • 14.1.3 PROSOMNUS SLEEP TECHNOLOGIES
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Deals
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 DYNAFLEX
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Deals
  • 14.1.5 VIVOS THERAPEUTICS, INC.
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Product approvals
      • 14.1.5.3.2 Deals
      • 14.1.5.3.3 Expansions
      • 14.1.5.3.4 Other developments
  • 14.1.6 OPENAIRWAY
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Deals
  • 14.1.7 PANTHERA DENTAL
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches
      • 14.1.7.3.2 Deals
      • 14.1.7.3.3 Other developments
  • 14.1.8 AIRWAY MANAGEMENT
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Product launches
  • 14.1.9 APNEA SCIENCES
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
  • 14.1.10 ORAVANOSA
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
  • 14.1.11 MYERSON LLC.
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
  • 14.1.12 BRAEBON MEDICAL CORPORATION
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
• 14.2 OTHER PLAYERS
  • 14.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
  • 14.2.2 THE SNORE RELIEVER COMPANY, LLC
  • 14.2.3 TOMED GMBH
  • 14.2.4 THE AURUM GROUP
  • 14.2.5 ERKODENT ENRICH KOPP GMBH
  • 14.2.6 OSCIMED SA
  • 14.2.7 SICAT GMBH & CO. KG
  • 14.2.8 GLIDEWELL
  • 14.2.9 APNOMED, INC.
  • 14.2.10 ZQUIET
  • 14.2.11 DREAM SYSTEMS DENTAL SLEEP LAB
  • 14.2.12 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC
  • 14.2.13 ORTHOAPNEA
  • 14.2.14 DOC BRANDS, INC.

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS